Search

everythinglearnresearchcommunity

for

Search:↓

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

A skin rash after the AstraZeneca COVID-19 vaccine was treated successfully with medication.

3D imaging effectively tracks skin changes in vitiligo treatment.

Topical tofacitinib helped a man with severe scalp condition after other treatments failed.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Rituximab can cause skin issues, but baricitinib may help improve them.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Etanercept may not prevent alopecia areata from coming back.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

Dermatologists are hesitant to prescribe Janus kinase inhibitors for alopecia areata due to safety concerns and lack of knowledge.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Tocilizumab might be an effective treatment for COVID-19.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

AQB reduces harmful skin changes in systemic sclerosis.

Rituximab improved her dermatomyositis better than usual treatments.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

JAK inhibitors are effective for long-term management of alopecia areata.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.